CEACAM5 and neoplasm: Soluble CEA could bind and block CEA-targeted therapies, but this deleterious effect has not been observed with bispecific anti-CEA x anti-CD3 antibodies [84] or CAR-T cells directed against CEA+ tumor cells [85].